CVS climbs ahead of Q1 earnings as analysts lift targets into May 6 report
CVS•CVS Health shares rose after investors positioned ahead of the company’s Q1 2026 earnings release scheduled for Wednesday, May 6, 2026 before the market open. The move follows a recent string of upbeat analyst actions that lifted multiple price targets into the report.
1) What’s moving the stock
CVS Health traded higher on Wednesday, May 6, 2026, as markets focused on the company’s first-quarter earnings catalyst. CVS is scheduled to report Q1 2026 results before the market opens, with the earnings conference call set for 8:00 a.m. ET—prompting pre-report positioning and volatility typical for a large-cap healthcare name heading into results. (marketbeat.com)
2) The near-term catalyst investors are watching
The key driver for today’s move is the imminent Q1 print, which is expected to address health-insurance medical cost trends and pharmacy/health-services execution. Consensus expectations referenced in widely circulated earnings calendars call for about $2.21 in EPS on roughly $94.97 billion of revenue, making any surprise versus these benchmarks—or commentary on utilization and margins—central to the stock reaction. ()
